Company Description
SWK Holdings Corporation, a specialty finance company that focuses on the healthcare sector.
It operates in two segments, Finance Receivables and Pharmaceutical Development.
The company provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors.
It also offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance.
In addition, the company engages in the pharmaceutical development, formulation and manufacturing, and licensing business through the Peptelligence platform.
Further, it intends to out-license its internal product pipeline to create novel formulations using its proprietary technology to develop treatments for patients and caregivers.
The company was formerly known as Kana Software, Inc. and changed its name to SWK Holdings Corporation in December 2009.
SWK Holdings Corporation was founded in 1996 and is headquartered in Dallas, Texas.
Country | United States |
IPO Date | Sep 23, 1999 |
Industry | Asset Management |
Sector | Financial Services |
Employees | 22 |
CEO | Jody. D Staggs |
Contact Details
Address: 14755 Preston Road Dallas, Texas United States | |
Website | https://www.swkhold.com |
Stock Details
Ticker Symbol | SWKH |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001089907 |
CUSIP Number | 78501P203 |
ISIN Number | US78501P2039 |
Employer ID | 77-0435679 |
SIC Code | 6159 |
Key Executives
Name | Position |
---|---|
Jody. D Staggs | Chief Executive Officer & President |
Adam Christopher Rice CPA | Chief Financial Officer and Principal Financial & Accounting Officer |
Courtney Baker CPA | Controller |
David R. Earhart | General Counsel & Secretary |
John David Tamas | Director of Underwriting |
Kendall Papathanasiou | Director of HR |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 15, 2024 | 8-K | Current Report |
Nov 14, 2024 | 8-K | Current Report |
Nov 14, 2024 | 10-Q | Quarterly Report |
Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Nov 01, 2024 | 3 | Filing |
Nov 01, 2024 | 3 | Filing |
Nov 01, 2024 | 3 | Filing |
Nov 01, 2024 | 3 | Filing |
Nov 01, 2024 | 3 | Filing |
Nov 01, 2024 | 3 | Filing |